Pharmacokinetic and Pharmacodynamic Analysis of Subcutaneous Tocilizumab in PatientsWith Rheumatoid Arthritis From 2 Randomized, Controlled Trials: SUMMACTA and BREVACTA

Abdallah, H; Hsu, JC; Lu, P; Fettner, S; Zhang, XP; Douglass, W; Bao, M; Rowell, L; Burmester, GR; Kivitz, A

Abdallah, H (reprint author), 430 E 29th St, New York, NY 10016 USA.

JOURNAL OF CLINICAL PHARMACOLOGY, 2017; 57 (4): 459

Abstract

Tocilizumab is a humanized anti-interleukin-6 receptor antibody for treating rheumatoid arthritis. Pharmacokinetic/pharmacodynamic analysis was perfor......

Full Text Link